| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.089 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.032 | 0.6 |